期刊文献+

紫杉醇注射液60例药物不良反应分析 被引量:2

Analysis of Paclitaxel Injection'Side-effect of 60 cases
下载PDF
导出
摘要 目的:分析紫杉醇的不良反应。方法:对本院2010年1月-2011年6月60例使用紫杉醇发生不良反应的患者资料进行回顾性分析。结果:紫杉醇的主要不良反应有恶心呕吐、过敏反应、骨髓抑制、胃肠道反应、关节肌肉痛、心脏毒性等,经治疗后治愈29例,好转28例,肾功能损伤1例,永久性脱发2例。结论:紫杉醇应用于临床应多询问患者临床反应,密切观察化疗期间的体征变化,权衡利弊或提早预防,对症处理胃肠道反应、关节酸痛、周围神经炎、骨髓抑制等不良反应,以保证患者安全有效用药。 Objective:To analyze the side-effects of paclitaxel injection.Method: 60 patients who underwent the side-effects of paclitaxel injection from January 2010 - June 2011 were analyzed retrospectively.Result:The main side-effects of paclitaxel injection including nausea and vomiting, allergic reactions, bone marrow suppression, gastrointestinal tract, joint and muscle pain and cardiac toxicity, 60 patients were cured 29 cases, 28 patients were improved, 1 patient happened renal injury, 2 patients happened a permanent hair loss.Conclusion:When Paclitaxel injection was used in clinic should ask patients about clinical response, closely observed during chemotherapy signs of change, Balance advantages and disadvantages or make early prevention of symptomatic treatment of gastrointestinal reactions, which is joint pain, peripheral neuropathy, bone marrow suppression and other side-effect, in order to ensure the safe, effective drug-use in patients.
作者 张春芳
出处 《中国医学创新》 CAS 2012年第23期146-147,共2页 Medical Innovation of China
关键词 紫杉醇 药物不良反应 治疗 预防 Paclitaxel Adverse drug reactions Treatment Prevention
  • 相关文献

参考文献6

二级参考文献43

共引文献116

同被引文献19

  • 1Davidson NG.Single-agent paclitaxel as first line treatment of metastatic breast cancer:The British experience[J].SeminOncol,1996,23(5):6.
  • 2Szebeni J,Muggia FM,Alving CR.Complement activation by Cremophor ELas a possible contributor to hypersensitivity to paclitaxel:An in vitro study[J].J Natl Cancer Inst,1998,90(4):300.
  • 3Nabholtz JM,Gelmon K,Bontenbal M,et al.Multicenter randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer[J].J Clin Oncol,1996,14(6):1858.
  • 4Kutuk O, Letai A. Displacement of Bin by Bmf and Puma rather than increase in Bim level mediates paclitaxl-induced apoptosis in breast cancer celld[J]. Cell Death Differ, 2010, 17 ( 10 ) : 1624-1635.
  • 5Dhanikula R S, Dhanikula A B, Panchanula R, et al. Thermoreversible liposomal poloxamerel for the delivery of paclitaxel : dose proportionality and hematological toxicity studies[J]. Pharmazie, 2008, 63 ( 6 ) : 439-445.
  • 6Srivastava V, Negi A S, Kumar J K, et al. Plant-based anticancer molecules: A chemical and biological profile of some important leads[J].Bioorganic & Medicinal Chemistry, 2005, 13 ( 21 ) : 5892- 5908.
  • 7Anil K S, Alka G, Deepika A. Paelitaxel and its formulations[J]. Int J Pharm, 2002, 235 ( 122 ) : 179-192.
  • 8] Hill P B, Dora K A, Hughes A D. The involvement of intracellular Ca2+ in 5-HT ( IB/1D ) receptor-mediated contraction of the rabbit isolated renal artery[J]. BrJ Pharmacol, 2000, 130 ( 4 ) : 835-842.
  • 9Reinecke P, Knopf C, Schmitz M, et al. Growth inhibitory effects of Paclitaxel on human epitheliod sarcoma in vitro[J].Cancer, 2000, 88 ( 7 ) : 1614-1622.
  • 10Swanson P E, Carroll S B, Zhang X F, et al. Spontaneous premature chromosome condensation, micronucleus formation, and non-apoptotic cell death in heart Hela $3 cell Uhrastructural observations[J].Am J Pathol, 1995, 146 ( 4 ) : 963-971.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部